Business Context and Reporting Period
This Form 8-K Current Report was filed by Coda Octopus Group, Inc. (CODA) on April 10, 2024. The report discloses a corporate governance update regarding the expansion of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
The primary material change reported is the election of a new director to fill a vacancy created by the Board's recent expansion to seven seats.
- New Director: Gwenaël Rouy-Poirier was elected effective April 15, 2024.
- Compensation: Mr. Rouy-Poirier received an inducement grant of 7,898 shares of common stock, vesting on the first anniversary of his election.
Management Commentary and Background
Management selected Mr. Rouy-Poirier due to his strong financial background and ties to the defense industry. His recent experience includes:
- Independent consultant for aerospace and defense sectors (January 2024–present).
- Interim CFO for SHL Medical (May–December 2023).
- CFO of GKN Aerospace (April 2021–December 2022).
- CFO of Nobel Biocare Systems (2019–2021).
- Prior roles at Honeywell, L'Oréal, and Arthur Andersen.
Investor Verification Checklist
- Verify the effective date of the new director's term (April 15, 2024).
- Confirm the vesting schedule for the 7,898 share inducement grant.
- Review the total number of Board seats (expanded to seven) to understand the governance structure.
- Check for any subsequent filings regarding the other vacancy on the expanded Board.